Shanghai
688578.SSShanghai Allist Pharmaceuticals Co., Ltd. Price (688578.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
450,471,902
(0.1049)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Shanghai Allist Pharmaceuticals Co., Ltd.Currency: CNY
| YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
7,727,000.00
+0% |
4,619,965.00
-40% |
629,723.00
-86% |
560,887.00
-11% |
530,094,158.00
+94,410% |
791,002,454.00
+49% |
2,018,182,563.00
+155% |
||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 5,063,944.00 | 3,005,685.00 | 270,433.00 | 161,694.00 | 5,644,859.00 | 31,719,405.00 | 110,015,359.00 | ||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
2,663,056.00
+0% |
1,614,280.00
-39% |
359,290.00
-78% |
399,193.00
+11% |
524,449,299.00
+131,277% |
759,283,049.00
+45% |
1,908,167,204.00
+151% |
||||||||||||
| Gross Profit Ratio | (0.34%) | (0.35%) | (0.57%) | (0.71%) | (0.99%) | (0.96%) | (0.95%) | ||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 37,912,577.00 | 92,487,038.00 | 161,998,901.00 | 177,962,990.00 | 222,594,854.00 | 191,750,085.00 | 313,059,372.00 | ||||||||||||
| General and Administrative | 4,051,399.00 | 6,228,997.00 | 13,093,971.00 | 19,710,341.00 | 15,099,590.00 | 15,728,310.00 | 22,900,294.00 | ||||||||||||
| Selling, General & Admin... | 4,051,399.00 | 6,228,997.00 | 13,093,971.00 | 111,877,773.00 | 283,710,341.00 | 447,389,641.00 | 1,032,882,582.00 | ||||||||||||
| Selling & Marketing Exp... | 0.00 | 0.00 | 0.00 | 92,167,431.00 | 268,610,751.00 | 431,661,331.00 | 603,604,132.00 | ||||||||||||
| Depreciation and Amortiz... | 4,166,900.00 | 5,046,300.00 | 9,536,600.00 | 12,495,891.00 | 25,713,172.00 | 27,022,310.00 | 40,185,838.00 | ||||||||||||
| Other Expenses | -135,323.18 | 868,297.00 | 218,409,281.00 | 49,129,256.00 | 67,667,053.00 | 73,872,638.00 | -95,442,784.00 | ||||||||||||
| Total Operating Expenses | 51,291,377.00 | 108,136,939.00 | 393,502,154.00 | 338,970,020.00 | 573,972,249.00 | 713,012,365.00 | 1,250,499,170.00 | ||||||||||||
| Cost and Exponses | 56,355,321.00 | 111,142,624.00 | 393,772,588.00 | 339,131,714.00 | 579,617,109.00 | 744,731,770.00 | 1,360,514,529.00 | ||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-38,798,481.07
+0% |
-98,262,106.94
+153% |
-393,142,864.70
+300% |
-338,570,827.34
-14% |
-49,522,951.26
-85% |
94,644,935.00
-291% |
657,668,034.00
+595% |
||||||||||||
| Operating Income Ratio | (-5.02%) | (-21.27%) | (-624.31%) | (-603.63%) | (-0.09%) | (0.12%) | (0.33%) | ||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 649,549.00 | 184,661.00 | 3,281,754.00 | 5,994,373.00 | 12,180,141.00 | 20,405,080.00 | 50,278,270.00 | ||||||||||||
| Interest Expenses | 4,241,679.00 | 6,017,919.00 | 7,278,780.00 | 1,144,549.00 | 605,051.00 | 325,323.00 | 206,082.00 | ||||||||||||
| Total Other Income/Exp... | -135,323.25 | 868,296.00 | -4,359,629.36 | -63,501.14 | -3,553,582.00 | -1,815,582.00 | -1,446,802.00 | ||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -30,513,502.00 | -86,284,010.00 | -380,150,793.00 | -296,826,444.00 | 44,626,081.00 | 153,382,821.00 | 696,613,153.00 | ||||||||||||
| EBITDA ratio | (-3.87%) | (-18.68%) | (-611.38%) | (-545.15%) | (-0.01%) | (0.15%) | (0.35%) | ||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -38,933,804.25 | -97,393,809.35 | -397,502,494.06 | -310,515,172.14 | 18,274,567.00 | 125,998,903.00 | 656,221,232.00 | ||||||||||||
| Income Before Tax Ratio | (-5.04%) | (-21.08%) | (-631.23%) | (-553.61%) | (0.03%) | (0.16%) | (0.33%) | ||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 4,692,258.00 | 6,886,216.00 | 2,968,102.00 | -7,115,784.76 | -44,702,453.19 | -4,521,773.88 | 12,046,413.00 | ||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | -38,933,804.25
+0% |
-97,393,809.35
+150% |
-400,470,596.95
+311% |
-303,399,387.38
-24% |
62,977,020.00
-121% |
130,520,677.00
+107% |
644,174,819.00
+394% |
||||||||||||
| Net Income Ratio | (-5.04%) | (-21.08%) | (-635.95%) | (-540.93%) | (0.12%) | (0.17%) | (0.32%) | ||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -0.11 | -0.27 | -0.89 | -0.67 | 0.14 | 0.29 | 1.43 | ||||||||||||
| Diluted EPS | -0.11 | -0.27 | -0.89 | -0.67 | 0.14 | 0.29 | 1.43 | ||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 361,365,904.00 | 361,365,904.00 | 450,000,000.00 | 450,000,000.00 | 450,000,000.00 | 450,000,000.00 | 450,471,902.00 | ||||||||||||
| Diluted Share Outstanding | 361,365,904.00 | 361,365,904.00 | 450,000,000.00 | 450,000,000.00 | 450,000,000.00 | 450,000,000.00 | 450,471,902.00 | ||||||||||||